Search Results - Ong, Tee-Chuan

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    The Outcome of HyperCVAD Combined with Alemtuzumab for the Treatment of Aggressive T-Cell and NK-Cell Neoplasms.

    The Outcome of HyperCVAD Combined with Alemtuzumab for the Treatment of Aggressive T-Cell and NK-Cell Neoplasms. by Kuan, Jew-Win, Chang, Kian-Meng, Lau, Ngee Siang, Visalachy, Purushothaman, Tan, Sen Mui, Ong, Tee Chuan, Su, Anselm-Ting

    Published 2011
    Get full text
    Get full text
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Clinical Significance of BCL2, C-MYC, and BCL6 Genetic Abnormalities, Epstein-Barr Virus Infection, CD5 Protein Expression, Germinal Center B Cell/Non-Germinal Center B-Cell Subtypes, Co-expression of MYC/BCL2 Proteins and Co-expression of MYC/BCL2/BCL6 Proteins in Diffuse Large B-Cell Lymphoma : A Clinical and Pathological Correlation Study of 120 Patients

    Clinical Significance of BCL2, C-MYC, and BCL6 Genetic Abnormalities, Epstein-Barr Virus Infection, CD5 Protein Expression, Germinal Center B Cell/Non-Germinal Center B-Cell Sub... by Kuan, Jew-Win, Ting, Choo Yuen, Chang, K. M., Jameela, Sathar, Chew, Lee Ping, Wong, Jacqueline Oy-Leng, Yusri, Yusuf, Lily, Wong, Ahmad Toha, Samsudin, Mohd Nurjaya, Bin Mohd Pana, Lee, Suk Kam, Raja Gopal, Navarasi S., Rita, Puri, Ong, Tee-Chuan, Samsol Kamal, Bahari, Goh, Ai-Sim, Teoh, Ching- Soon

    Published 2019
    Get full text
    Get full text
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: